N

Nanobiotix SA
D

NBTX

4.39000
USD
-0.09
(-2.01%)
مفتوح الان
حجم التداول
7
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
208,106,778
أصول ذات صلة
ABT
ABT
-0.085
(-0.06%)
133.140 USD
AZN
AZN
0.560
(0.80%)
70.570 USD
BNTX
BNTX
-3.650
(-3.42%)
102.970 USD
GSK
GSK
0.145
(0.38%)
38.190 USD
JNJ
JNJ
1.120
(0.75%)
151.010 USD
MRK
MRK
0.890
(1.13%)
80.180 USD
MRNA
MRNA
-0.230
(-0.89%)
25.690 USD
N
NVAX
-0.12500
(-1.95%)
6.29000 USD
PFE
PFE
-0.015
(-0.06%)
23.990 USD
REGN
REGN
1.18
(0.23%)
510.88 USD
TAK
TAK
-0.025
(-0.17%)
14.735 USD
المزيد
الأخبار المقالات

العنوان: Nanobiotix SA

القطاع: Healthcare
الصناعة: Biotechnology
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.